File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Crowdsourcing To Promote Hepatitis C Testing And Linkage-to-care In China: Randomized Controlled Trial Interim Report

TitleCrowdsourcing To Promote Hepatitis C Testing And Linkage-to-care In China: Randomized Controlled Trial Interim Report
Authors
Issue Date2021
PublisherSpringer (India) Private Ltd. The Journal's web site is located at http://www.springer.com/medicine/internal/journal/12072
Citation
Asian Pacific Association for the Study of the Liver (APASL) 30th Annual Meeting 2021: Collaboration and Cure, Virtual Meeting, 4-6 February 2021. In Hepatology International, 2021, v. 15 n. Suppl. 1, p. S28, absract no. G-05 How to Cite?
AbstractObjectives: Many people living with HCV in China are unaware of their HCV status, despite a large burden of disease and increasing treatment access. Crowdsourcing has a group of individuals solve a problem (e.g., messaging to promote HCV testing and linkage) and then implement solutions. Materials and Methods: A two-armed randomized controlled trial is being con ducted at primary care sectors of Shenzhen among local residents >30 years old not known to have HCV. The intervention group would receive crowdsourcing materials to promote HCV testing twice a week for two weeks, while the control group received standard promotional materials. Those identified HCV antibody-positive would be referred to specialists for confirmation and treatment. Results: As of 4th November 2020, 614 persons were recruited into the study (311 in the intervention group and 303 in the control). 47.1% were male; majority married (81.6%) with an average age of 43.2 years. 490 (79.8%; 249 in the intervention vs 241 in the control) had been tested and 12 (8 in the intervention and 4 in the control) were found to be positive for HCV. Significantly more were tested at HKUSZH in the intervention group (129/179 in the intervention vs 105/197 in the control; p<0.001). In those detected HCV, there were significantly more who did not think HCV was a serious problem before (p=0.048). Discussion: This interim analysis demonstrates the feasibility and acceptability of this approach. This community-based hospital approach could be used to scale up HCV testing in many settings. (Chinese Clinical Trial Registry ChiCTR19000025771)
DescriptionPoster Presentation - Health Services Research - no. G-05
Organizer: Thai Association for Study of the Liver
Persistent Identifierhttp://hdl.handle.net/10722/298667
ISSN
2023 Impact Factor: 5.9
2023 SCImago Journal Rankings: 1.813

 

DC FieldValueLanguage
dc.contributor.authorWong, WCW-
dc.contributor.authorYang, NS-
dc.contributor.authorLi, J-
dc.contributor.authorLi, H-
dc.contributor.authorWan, EYF-
dc.contributor.authorFitzpatrick, T-
dc.contributor.authorXiong, Y-
dc.contributor.authorChan, P-
dc.contributor.authorLiu, R-
dc.contributor.authorTang, WM-
dc.contributor.authorSeto, WKW-
dc.contributor.authorTucker, J-
dc.date.accessioned2021-04-12T03:01:42Z-
dc.date.available2021-04-12T03:01:42Z-
dc.date.issued2021-
dc.identifier.citationAsian Pacific Association for the Study of the Liver (APASL) 30th Annual Meeting 2021: Collaboration and Cure, Virtual Meeting, 4-6 February 2021. In Hepatology International, 2021, v. 15 n. Suppl. 1, p. S28, absract no. G-05-
dc.identifier.issn1936-0533-
dc.identifier.urihttp://hdl.handle.net/10722/298667-
dc.descriptionPoster Presentation - Health Services Research - no. G-05-
dc.descriptionOrganizer: Thai Association for Study of the Liver-
dc.description.abstractObjectives: Many people living with HCV in China are unaware of their HCV status, despite a large burden of disease and increasing treatment access. Crowdsourcing has a group of individuals solve a problem (e.g., messaging to promote HCV testing and linkage) and then implement solutions. Materials and Methods: A two-armed randomized controlled trial is being con ducted at primary care sectors of Shenzhen among local residents >30 years old not known to have HCV. The intervention group would receive crowdsourcing materials to promote HCV testing twice a week for two weeks, while the control group received standard promotional materials. Those identified HCV antibody-positive would be referred to specialists for confirmation and treatment. Results: As of 4th November 2020, 614 persons were recruited into the study (311 in the intervention group and 303 in the control). 47.1% were male; majority married (81.6%) with an average age of 43.2 years. 490 (79.8%; 249 in the intervention vs 241 in the control) had been tested and 12 (8 in the intervention and 4 in the control) were found to be positive for HCV. Significantly more were tested at HKUSZH in the intervention group (129/179 in the intervention vs 105/197 in the control; p<0.001). In those detected HCV, there were significantly more who did not think HCV was a serious problem before (p=0.048). Discussion: This interim analysis demonstrates the feasibility and acceptability of this approach. This community-based hospital approach could be used to scale up HCV testing in many settings. (Chinese Clinical Trial Registry ChiCTR19000025771)-
dc.languageeng-
dc.publisherSpringer (India) Private Ltd. The Journal's web site is located at http://www.springer.com/medicine/internal/journal/12072-
dc.relation.ispartofHepatology International-
dc.relation.ispartofThe 30th Asian Pacific Association for the Study of Liver (APASL) Annual Meeting, 2021-
dc.titleCrowdsourcing To Promote Hepatitis C Testing And Linkage-to-care In China: Randomized Controlled Trial Interim Report-
dc.typeConference_Paper-
dc.identifier.emailWong, WCW: wongwcw@hku.hk-
dc.identifier.emailWan, EYF: yfwan@hku.hk-
dc.identifier.emailSeto, WKW: wkseto@hku.hk-
dc.identifier.authorityWong, WCW=rp01457-
dc.identifier.authorityWan, EYF=rp02518-
dc.identifier.authoritySeto, WKW=rp01659-
dc.description.natureabstract-
dc.identifier.hkuros322000-
dc.identifier.volume15-
dc.identifier.issueSuppl. 1-
dc.identifier.spageS28-
dc.identifier.epageS28-
dc.publisher.placeIndia-
dc.identifier.partofdoi10.1007/s12072-021-10213-7-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats